跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Treatan-D - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Treatan-D
Approved
STANDARD
Treatan-D
PharmEvo (Pvt.) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f2a23f9c7d7b0419
Company
PharmEvo (Pvt.) Limited
Type
Standard
Approval Details
Approval Id
f2a23f9c7d7b0419
Drug Approval Philippines Name
Treatan-D
Product Name
Treatan-D
Registration Number
DR-XY46078
Brand Name
Treatan-D
Generic Name
Candesartan Cilexetil + Hydrochlorothiazide
Dosage Form
Tablet
Dosage Strength
16mg/ 12.5mg
Manufacturer
PharmEvo (Pvt.) Limited
Importer
REG-A SOLUTIONS, INC.
Distributor
REG-A SOLUTIONS, INC.
Issuance Date
28 September 2022
Expiry Date
19 October 2027
Pharmacologic Category
Angiotensin II Antagonist + Diuretic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f2a23f9c7d7b0419
Type
Standard
Back to Philippines FDA Approvals